Neurocrine Biosciences Inc (NBIX)

Inventory turnover

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Cost of revenue US$ in thousands 1,044,800 930,800 776,400 583,300 433,300
Inventory US$ in thousands 57,400 38,300 35,100 30,500 28,000
Inventory turnover 18.20 24.30 22.12 19.12 15.48

December 31, 2024 calculation

Inventory turnover = Cost of revenue ÷ Inventory
= $1,044,800K ÷ $57,400K
= 18.20

Neurocrine Biosciences Inc's inventory turnover has shown a positive trend over the years, increasing from 15.48 in 2020 to 19.12 in 2021, further rising to 22.12 in 2022, and reaching 24.30 in 2023. This indicates that the company has been efficient in managing its inventory levels and converting them into sales. However, there was a slight decrease in inventory turnover to 18.20 in 2024. Overall, Neurocrine Biosciences Inc's inventory turnover ratios suggest effective inventory management practices and a healthy demand for its products during the period under review.